Arch Venture Management’s Maze Therapeutics MAZE Stock Holding History

Arch Venture Management’s Portfolio MAZE Stock Details MAZE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$123M	Hold	4,120,053	–	–	18.16%	1
2025 Q4	$171M	Hold	4,120,053	–	–	26.19%	1
2025 Q3	$107M	Hold	4,120,053	–	–	21.7%	3
2025 Q2	$50.6M	Hold	4,120,053	–	–	16.91%	3
2025 Q1	$45.4M	Buy	+4,120,053	New	+$49.6M	22%	2

Other funds holding MAZE

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return